AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33523128 — intervention group
Group type: COMPARATOR
Intervention: No strategy (NS)
Number of subjects: 429062
Study 33523128 — intervention group
Group type: COMPARATOR
Intervention: ID consultations
Number of subjects: 429062
Study 35287788 — intervention group
Group type: EXPERIMENTAL
Intervention: Apolla Performance Shock™ dance socks (DS)
Number of subjects: 21
Study 34488701 — intervention group
Group type: EXPERIMENTAL
Intervention: Antipsychotics (AP) withdrawal (pipamperone or risperidone); dose reduced by 25% every 4 weeks.
Number of subjects: 0
Study 34488701 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group); dose remains unaltered.
Number of subjects: 0
Study 32957204 — intervention group
Group type: EXPERIMENTAL
Intervention: Conical implants
Number of subjects: 25
Study 32957204 — intervention group
Group type: COMPARATOR
Intervention: Straight implants
Number of subjects: 25
Study 33593279 — intervention group
Group type: EXPERIMENTAL
Intervention: High leisure-time physical activity (LTPA)
Number of subjects: 761
Study 33593279 — intervention group
Group type: COMPARATOR
Intervention: Low leisure-time physical activity (LTPA)
Number of subjects: 761
Study 32420318 — intervention group
Group type: EXPERIMENTAL
Intervention: PCV+OLA
Number of subjects: 176
Study 32420318 — intervention group
Group type: COMPARATOR
Intervention: PCV
Number of subjects: 176
Study 35577644 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemoradiotherapy (5-fluorouracil and mitomycin C with radiotherapy)
Number of subjects: 458
Study 34280472 — intervention group
Group type: EXPERIMENTAL
Intervention: miR‐185‐5p and miR‐425‐5p expression levels measured before radiation therapy
Number of subjects: 111
Study 34280472 — intervention group
Group type: EXPERIMENTAL
Intervention: miR‐185‐5p and miR‐425‐5p expression levels measured after 20 Gy
Number of subjects: 111
Study 34280472 — intervention group
Group type: EXPERIMENTAL
Intervention: Model including pretreatment miR‐185‐5p and miR‐425‐5p levels with mean parotid dose
Number of subjects: 111
Study 34280472 — intervention group
Group type: EXPERIMENTAL
Intervention: miR‐185‐5p and miR‐425‐5p levels after 20 Gy with mean parotid dose
Number of subjects: 111
Study 34280472 — intervention group
Group type: EXPERIMENTAL
Intervention: miR‐185‐5p and miR‐425‐5p levels after 20 Gy
Number of subjects: 111
Study 34280472 — intervention group
Group type: EXPERIMENTAL
Intervention: Model application in validation cohort
Number of subjects: 111
Study 34081897 — intervention group
Group type: EXPERIMENTAL
Intervention: DNA-based assays (Digene Hybrid Capture 2 High-Risk HPV DNA Test and cobas 4800 HPV Test)
Number of subjects: 12982
Study 34081897 — intervention group
Group type: COMPARATOR
Intervention: RNA-based assay (Aptima HPV Assay)
Number of subjects: 12982
Study 34806780 — intervention group
Group type: EXPERIMENTAL
Intervention: Professional-mode flash glucose monitoring
Number of subjects: 299
Study 34806780 — intervention group
Group type: COMPARATOR
Intervention: Usual clinical care
Number of subjects: 299
Study 34368045 — intervention group
Group type: EXPERIMENTAL
Intervention: Video intervention
Number of subjects: 98
Study 34368045 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 98
Study 33565656 — intervention group
Group type: EXPERIMENTAL
Intervention: Autogenous whole tooth (AWTG)
Number of subjects: 20
Study 33565656 — intervention group
Group type: COMPARATOR
Intervention: Autogenous demineralized dentin graft (ADDG)
Number of subjects: 20
Study 34269160 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracic spine manipulation (TSM)
Number of subjects: 48
Study 34269160 — intervention group
Group type: COMPARATOR
Intervention: No treatment (Hold)
Number of subjects: 48
Study 33779542 — intervention group
Group type: EXPERIMENTAL
Intervention: Neck circumference/height ratio (NHR) cut point ≥ 0.21
Number of subjects: 6167
Study 33779542 — intervention group
Group type: EXPERIMENTAL
Intervention: Waist circumference/height ratio (WHR) cut point ≥ 0.52
Number of subjects: 6167
Study 33779542 — intervention group
Group type: EXPERIMENTAL
Intervention: NHR, WHR, and derived STOP‐Bang Questionnaire (dSBQ) areas under the receiver operator curves
Number of subjects: 6167
Study 33779542 — intervention group
Group type: COMPARATOR
Intervention: Comparison of NHR and dSBQ areas under the receiver operator curves
Number of subjects: 6167
Study 33779542 — intervention group
Group type: COMPARATOR
Intervention: Comparison of WHR and dSBQ areas under the receiver operator curves
Number of subjects: 6167
Study 35363163 — intervention group
Group type: EXPERIMENTAL
Intervention: Sauti ya Vijana (SYV) mental health intervention
Number of subjects: 21
Study 35363163 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 21
Study 34163141 — intervention group
Group type: COMPARATOR
Intervention: 25 mg tenofovir alafenamide tablets (test formulation)
Number of subjects: 74
Study 32800407 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic mesh
Number of subjects: 242
Study 32800407 — intervention group
Group type: COMPARATOR
Intervention: Conventional stoma construction (Control)
Number of subjects: 242
Study 36331152 — intervention group
Group type: EXPERIMENTAL
Intervention: High-protein diet combined with exercise
Number of subjects: 13
Study 36331152 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 13
Study 32228534 — intervention group
Group type: EXPERIMENTAL
Intervention: Bespoke communication training for health professionals
Number of subjects: 58
Study 32228534 — intervention group
Group type: EXPERIMENTAL
Intervention: Health professionals' presentation of treatment arms
Number of subjects: 58
Study 32228534 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative analysis of recruitment consultations
Number of subjects: 58
Study 32228534 — intervention group
Group type: EXPERIMENTAL
Intervention: Interviews with families
Number of subjects: 58
Study 34030517 — intervention group
Group type: EXPERIMENTAL
Intervention: SuperPATH approach
Number of subjects: 44
Study 34030517 — intervention group
Group type: COMPARATOR
Intervention: MPA approach
Number of subjects: 44
Study 34030517 — intervention group
Group type: EXPERIMENTAL
Intervention: Both approaches
Number of subjects: 44
Study 34002007 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate to vigorous physical activity
Number of subjects: 157
Study 34002007 — intervention group
Group type: COMPARATOR
Intervention: Sedentary or light physical activity
Number of subjects: 157
Study 32295773 — intervention group
Group type: EXPERIMENTAL
Intervention: HABIT (habit formation of parental support)
Number of subjects: 240
Study 32295773 — intervention group
Group type: COMPARATOR
Intervention: PLANNING (planning and education group)
Number of subjects: 240
Study 32295773 — intervention group
Group type: COMPARATOR
Intervention: EDUCATION (education only group)
Number of subjects: 240
Study 36002221 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal progesterone
Number of subjects: 960
Study 36002221 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical pessary
Number of subjects: 960
Study 36002221 — intervention group
Group type: COMPARATOR
Intervention: Both interventions
Number of subjects: 960
Study 34814893 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational program based on Theory of Planned Behavior (TPB) conducted in six educational sessions.
Number of subjects: 64
Study 34814893 — intervention group
Group type: COMPARATOR
Intervention: Routine education about lifestyle changes including osteoporosis.
Number of subjects: 64
Study 32183810 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured drug review using the STRIP method assisted by a clinical decision support system (STRIP Assistant, STRIPA) with integrated STOPP/START criteria (version 2)
Number of subjects: 0
Study 32183810 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured drug review
Number of subjects: 0
Study 32183810 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical decision support system (CDSS)
Number of subjects: 0
Study 32183810 — intervention group
Group type: EXPERIMENTAL
Intervention: STOPP/START criteria application
Number of subjects: 0
Study 32183810 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-component intervention
Number of subjects: 0
Study 35148407 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness Meditation + Respiratory-Gated Auricular Vagal Afferent Nerve Stimulation (MM+RAVANS)
Number of subjects: 19
Study 35148407 — intervention group
Group type: COMPARATOR
Intervention: Mindfulness Meditation + Sham Stimulation (MM+Sham)
Number of subjects: 19
Study 32985121 — intervention group
Group type: EXPERIMENTAL
Intervention: NeuroSAFE RARP
Number of subjects: 49
Study 32985121 — intervention group
Group type: COMPARATOR
Intervention: Standard RARP
Number of subjects: 49
Study 32232885 — intervention group
Group type: EXPERIMENTAL
Intervention: Consolidated therapy group (CTG) with balneotherapy and Chinese herbal medicine (CHM)
Number of subjects: 200
Study 32232885 — intervention group
Group type: COMPARATOR
Intervention: Unconsolidated therapy group (UTG)
Number of subjects: 200
Study 34475270 — intervention group
Group type: EXPERIMENTAL
Intervention: Large monthly cash gift
Number of subjects: 1000
Study 34475270 — intervention group
Group type: COMPARATOR
Intervention: Nominal monthly cash gift
Number of subjects: 1000
Study 35960650 — intervention group
Group type: EXPERIMENTAL
Intervention: ses-IgE-based predictor
Number of subjects: 331
Study 34008228 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold pack applied for 6 hours post-operation
Number of subjects: 100
Study 34008228 — intervention group
Group type: COMPARATOR
Intervention: Standard postoperative care
Number of subjects: 100
Study 32482669 — intervention group
Group type: EXPERIMENTAL
Intervention: Photobiomodulation (PBM) therapy associated with supervised therapeutic exercises (STEP)
Number of subjects: 120
Study 32482669 — intervention group
Group type: COMPARATOR
Intervention: Supervised therapeutic exercises (STEP) alone
Number of subjects: 120
Study 35815057 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based cardiac rehabilitation (long-distance family rehabilitation nursing intervention)
Number of subjects: 80
Study 35815057 — intervention group
Group type: COMPARATOR
Intervention: Traditional outpatient rehabilitation (control group)
Number of subjects: 80
Study 32737637 — intervention group
Group type: EXPERIMENTAL
Intervention: Open total gastrectomy (OTG)
Number of subjects: 96
Study 32737637 — intervention group
Group type: COMPARATOR
Intervention: Minimally invasive total gastrectomy (MITG)
Number of subjects: 96
Study 34341046 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-befriending intervention
Number of subjects: 28
Study 34341046 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care + peer-befriending
Number of subjects: 28
Study 34341046 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 28
Study 32057962 — intervention group
Group type: EXPERIMENTAL
Intervention: 30-min plasma glucose measurement during OGTT
Number of subjects: 548
Study 32057962 — intervention group
Group type: EXPERIMENTAL
Intervention: 30-min plasma glucose >182 mg/dl
Number of subjects: 548
Study 34952123 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine (300 mg/day)
Number of subjects: 770
Study 34952123 — intervention group
Group type: COMPARATOR
Intervention: Lithium (two different doses)
Number of subjects: 770
Study 34952123 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment without lithium
Number of subjects: 770
Study 33733337 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiomics model combined with clinical factors
Number of subjects: 153
Study 33733337 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mm peritumoral radiomics model
Number of subjects: 153
Study 33733337 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mm peritumoral radiomics model
Number of subjects: 153
Study 33733337 — intervention group
Group type: EXPERIMENTAL
Intervention: Tumoral radiomics model
Number of subjects: 153
Study 33733337 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined T + PT model
Number of subjects: 153
Study 33155169 — intervention group
Group type: EXPERIMENTAL
Intervention: NLP algorithm for abstracting MPI reports
Number of subjects: 16957
Study 33155169 — intervention group
Group type: COMPARATOR
Intervention: Patients with abnormal MPI results
Number of subjects: 16957
Study 34154603 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 mg Capsiate (CAP)
Number of subjects: 20
Study 34154603 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 20
Study 32757317 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 IU daily of cholecalciferol
Number of subjects: 50
Study 32757317 — intervention group
Group type: COMPARATOR
Intervention: 400 IU daily of cholecalciferol (Control)
Number of subjects: 50
Study 32757317 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum 25(OH) vitamin D
Number of subjects: 50
Study 35490873 — intervention group
Group type: EXPERIMENTAL
Intervention: GDMT titrated to achieve NT-proBNP <1000 pg/mL
Number of subjects: 894
Study 35490873 — intervention group
Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 894
Study 33551349 — intervention group
Group type: EXPERIMENTAL
Intervention: PPI alone
Number of subjects: 156
Study 33551349 — intervention group
Group type: EXPERIMENTAL
Intervention: PPI + rebamipide
Number of subjects: 156
Study 33551349 — intervention group
Group type: EXPERIMENTAL
Intervention: H2RA + rebamipide
Number of subjects: 156
Study 33551349 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 156
Study 35245225 — intervention group
Group type: EXPERIMENTAL
Intervention: Scalpel-Finger-Cannula (SFC)
Number of subjects: 65
Study 35245225 — intervention group
Group type: COMPARATOR
Intervention: Scalpel-Finger-Bougie (SFB)
Number of subjects: 65
Study 36204783 — intervention group
Group type: EXPERIMENTAL
Intervention: Ozone therapy
Number of subjects: 53
Study 34193622 — intervention group
Group type: EXPERIMENTAL
Intervention: Ergonomic infant carrier and instruction on proper use
Number of subjects: 100
Study 34193622 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 100
Study 32289715 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency (20 Hz) unilateral rTMS over the left DLPFC
Number of subjects: 100
Study 32289715 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 100
Study 36030457 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-week HRV biofeedback intervention
Number of subjects: 165
Study 32965802 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose furosemide (2.5 mg/kg)
Number of subjects: 21
Study 32965802 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose furosemide (5 mg/kg)
Number of subjects: 21
Study 32965802 — intervention group
Group type: COMPARATOR
Intervention: Control (normal saline)
Number of subjects: 21
Study 32883286 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultra-sensitive HRP2-based Alere™ Malaria Ag P.f RDT (uRDT)
Number of subjects: 0
Study 32883286 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel algorithm using HRP2:pLDH ratios
Number of subjects: 0
Study 34984794 — intervention group
Group type: EXPERIMENTAL
Intervention: linagliptin 5 mg once daily for 8 days
Number of subjects: 29
Study 34518314 — intervention group
Group type: EXPERIMENTAL
Intervention: Rescube tool with a cuddly toy (n = 61)
Number of subjects: 237
Study 34518314 — intervention group
Group type: EXPERIMENTAL
Intervention: Endless Book tool with a cuddly toy (n = 74)
Number of subjects: 237
Study 34518314 — intervention group
Group type: COMPARATOR
Intervention: Traditional teaching with a cuddly toy (n = 46)
Number of subjects: 237
Study 34518314 — intervention group
Group type: COMPARATOR
Intervention: Traditional teaching with a manikin (n = 55)
Number of subjects: 237
Study 32397609 — intervention group
Group type: EXPERIMENTAL
Intervention: ProBeptigen®
Number of subjects: 90
Study 32397609 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 36427543 — intervention group
Group type: EXPERIMENTAL
Intervention: Cottonseed oil (CSO) diet
Number of subjects: 42
Study 36427543 — intervention group
Group type: COMPARATOR
Intervention: Olive oil (OO) diet
Number of subjects: 42
Study 33657998 — intervention group
Group type: EXPERIMENTAL
Intervention: Mulligan Manual Therapy (MMT) and exercise
Number of subjects: 297
Study 33657998 — intervention group
Group type: COMPARATOR
Intervention: Placebo and exercise
Number of subjects: 297
Study 33657998 — intervention group
Group type: COMPARATOR
Intervention: Exercise alone
Number of subjects: 297
Study 36178575 — intervention group
Group type: EXPERIMENTAL
Intervention: Lymph node dissections (LNDs) ≥ 10
Number of subjects: 26517
Study 36178575 — intervention group
Group type: COMPARATOR
Intervention: Lymph node dissections (LNDs) ≤ 9
Number of subjects: 26517
Study 35725141 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily physical activity promotion text messages
Number of subjects: 0
Study 35725141 — intervention group
Group type: COMPARATOR
Intervention: Control group (1 neutral message related to general health information weekly)
Number of subjects: 0
Study 36111824 — intervention group
Group type: EXPERIMENTAL
Intervention: iN2L tablets and access to Alzheimer's Association supportive programs
Number of subjects: 124
Study 34730890 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (800 IU in drops for three months)
Number of subjects: 97
Study 34730890 — intervention group
Group type: COMPARATOR
Intervention: Control group (no vitamin D supplementation)
Number of subjects: 97
Study 34730890 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 97
Study 34730890 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 97
Study 32544125 — intervention group
Group type: EXPERIMENTAL
Intervention: Panic Control Therapy (PCT)
Number of subjects: 66
Study 32544125 — intervention group
Group type: COMPARATOR
Intervention: PCT and in vivo exposures to agoraphobic situations (PCT + IV)
Number of subjects: 66
Study 34511168 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfacalcidol (0.25 μg/d) for 4 weeks
Number of subjects: 200
Study 34511168 — intervention group
Group type: COMPARATOR
Intervention: Control group (vitamin C, rutin tablets, dipyridamole, cimetidine, calcium supplements, glucocorticoids)
Number of subjects: 200
Study 32067367 — intervention group
Group type: EXPERIMENTAL
Intervention: Broad-spectrum AMPA reactivity (6–8 reactivities)
Number of subjects: 75
Study 32067367 — intervention group
Group type: COMPARATOR
Intervention: Moderate AMPA reactivity (3–5 reactivities)
Number of subjects: 75
Study 32067367 — intervention group
Group type: COMPARATOR
Intervention: Narrow AMPA reactivity (1–2 reactivities)
Number of subjects: 75
Study 32067367 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressors to RA
Number of subjects: 75
Study 32067367 — intervention group
Group type: EXPERIMENTAL
Intervention: Broad AMPA reactivity
Number of subjects: 75
Study 32067367 — intervention group
Group type: COMPARATOR
Intervention: Medium AMPA reactivity
Number of subjects: 75
Study 32067367 — intervention group
Group type: COMPARATOR
Intervention: Narrow AMPA reactivity
Number of subjects: 75
Study 32067367 — intervention group
Group type: EXPERIMENTAL
Intervention: High number of cortical microchannels
Number of subjects: 75
Study 32067367 — intervention group
Group type: COMPARATOR
Intervention: Low number of cortical microchannels
Number of subjects: 75
Study 33314384 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidomain lifestyle-based intervention
Number of subjects: 0
Study 33314384 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidomain FINGER concept
Number of subjects: 0
Study 32955023 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen
Number of subjects: 154
Study 32955023 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 154
Study 32955023 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (Acetaminophen + Ibuprofen)
Number of subjects: 154
Study 34010531 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive treatment target (systolic blood pressure <120 mm Hg)
Number of subjects: 9361
Study 34010531 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment target (systolic blood pressure <140 mm Hg)
Number of subjects: 9361
Study 32621071 — intervention group
Group type: EXPERIMENTAL
Intervention: 1064 mg q8wk
Number of subjects: 104
Study 32621071 — intervention group
Group type: EXPERIMENTAL
Intervention: 882 mg q6wk
Number of subjects: 104
Study 32621071 — intervention group
Group type: EXPERIMENTAL
Intervention: 441 mg q4wk
Number of subjects: 104
Study 35017008 — intervention group
Group type: EXPERIMENTAL
Intervention: Bicalutamide 150mg daily
Number of subjects: 3103
Study 35017008 — intervention group
Group type: COMPARATOR
Intervention: LHRHa
Number of subjects: 3103
Study 33345567 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-month DAPT
Number of subjects: 972
Study 33345567 — intervention group
Group type: COMPARATOR
Intervention: 12-month DAPT
Number of subjects: 972
Study 33345567 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-month DAPT with Orsiro stents
Number of subjects: 972
Study 33345567 — intervention group
Group type: COMPARATOR
Intervention: 3-month DAPT with everolimus-eluting stents
Number of subjects: 972
Study 36371125 — intervention group
Group type: EXPERIMENTAL
Intervention: Restorative Practices (RP) Project schools
Number of subjects: 5878
Study 36371125 — intervention group
Group type: COMPARATOR
Intervention: Comparison schools
Number of subjects: 5878
Study 35062874 — intervention group
Group type: EXPERIMENTAL
Intervention: VAC-optimized group (n = 41)
Number of subjects: 83
Study 35062874 — intervention group
Group type: COMPARATOR
Intervention: Usual care group (n = 42)
Number of subjects: 83
Study 33512329 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapist-guided, VR-based cognitive training intervention combined with treatment as usual
Number of subjects: 36
Study 33512329 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual without cognitive training
Number of subjects: 36
Study 34952187 — intervention group
Group type: EXPERIMENTAL
Intervention: Knotted suture anchors
Number of subjects: 64
Study 34952187 — intervention group
Group type: COMPARATOR
Intervention: Knotless suture anchors
Number of subjects: 64
Study 36228297 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TXA) administered during the induction of anesthesia
Number of subjects: 61
Study 36228297 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) without tranexamic acid
Number of subjects: 61
Study 33992509 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactate threshold (LT) jogging for 2 min
Number of subjects: 9